This grant is for the purpose of inviting exploratory and innovative research applications focused on the neurological and neuropsychiatric manifestations of COVID-19, known as neuro-COVID, and the lingering effects of SARS-CoV-2 infection, termed Post-Acute Sequelae (neuro-PASC). It also seeks research into COVID-19’s impact on pre-existing neurologic conditions. Specific interests include investigating the pathophysiology and underlying mechanisms of both neuro-COVID and neuro-PASC. The grant encourages neurologically-focused human subjects research and studies proposing scientifically compelling pathways to prevent the development of neuro-PASC or to accelerate the creation of effective treatments for PASC-related neurological complications. The goal is to deepen our comprehension and develop interventions for these critical health challenges.
Opportunity ID: 347184
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-NS-23-022 |
| Funding Opportunity Title: | Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 28, 2023 |
| Last Updated Date: | Mar 28, 2023 |
| Original Closing Date for Applications: | Feb 02, 2024 |
| Current Closing Date for Applications: | Feb 02, 2024 |
| Archive Date: | Mar 09, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $275,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Small businesses Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Private institutions of higher education City or township governments For profit organizations other than small businesses Native American tribal governments (Federally recognized) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to invite exploratory and innovative research applications focused on theneurological and neuropsychiatric manifestationsof COVID-19 (neuro-COVID) andPost-Acute Sequelae of SARS-CoV-2 Infection (neuro-PASC) and on the effect of COVID-19 on pre-infection neurologic conditions. Applications investigating the pathophysiology and mechanisms of neuro-COVID and neuro-PASC and neurologically-focused human subjects research, as well as those proposing studies of scientifically compelling pathways to prevent the development of neuro-PASC or to accelerate the development of effective treatments forPASC-related neurological complications are of particular interest for this NOFO. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-022.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 347184 Full Announcement-RFA-NS-23-022 -> RFA-NS-23-022-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00280867 | May 02, 2023 | Feb 02, 2024 | View |
Package 1
Mandatory forms
347184 RR_SF424_5_0-5.0.pdf
347184 PHS398_CoverPageSupplement_5_0-5.0.pdf
347184 RR_OtherProjectInfo_1_4-1.4.pdf
347184 PerformanceSite_4_0-4.0.pdf
347184 RR_KeyPersonExpanded_4_0-4.0.pdf
347184 PHS398_ResearchPlan_5_0-5.0.pdf
347184 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
347184 RR_Budget_3_0-3.0.pdf
347184 RR_SubawardBudget30_3_0-3.0.pdf
347184 PHS398_ModularBudget_1_2-1.2.pdf
347184 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
